Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus.

Dolores Isla Javier De Castro CarpeñoR García-CampeloPilar Lianes Enriqueta Felip Font Pilar Garrido Lopez Luis G Paz-AresJ M Trigo

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)

To support decision making following progression to immunotherapy-based treatment in patients with advanced wild-type lung adenocarcinoma, a consensus document has been developed.

Keyphrases

wild type
decision making
clinical practice
replacement therapy